These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The role of opioid antagonist efficacy and constitutive opioid receptor activity in the opioid withdrawal syndrome in mice. Navani DM; Sirohi S; Madia PA; Yoburn BC Pharmacol Biochem Behav; 2011 Oct; 99(4):671-5. PubMed ID: 21736895 [TBL] [Abstract][Full Text] [Related]
9. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. Bhargava HN; Thorat SN Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629 [TBL] [Abstract][Full Text] [Related]
10. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence. Schulteis G; Morse AC; Liu J Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263 [TBL] [Abstract][Full Text] [Related]
11. Barium potentiates the conditioned aversion to, but not the somatic signs of, morphine withdrawal in mice. Sato M; Wada K; Funada M Eur J Pharmacol; 2005 Sep; 519(3):215-22. PubMed ID: 16122731 [TBL] [Abstract][Full Text] [Related]
12. Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats. Olmstead MC; Burns LH Psychopharmacology (Berl); 2005 Sep; 181(3):576-81. PubMed ID: 16010543 [TBL] [Abstract][Full Text] [Related]
13. Ethanol attenuation of morphine dependence: comparison to dizocilpine. Shoemaker WJ; Kosten TA; Muly SM Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370 [TBL] [Abstract][Full Text] [Related]
14. The suppression of deprivation and antagonist-induced withdrawal in morphine-dependent rhesus monkeys. Gmerek DE Neuropeptides; 1984 Dec; 5(1-3):19-22. PubMed ID: 6099494 [TBL] [Abstract][Full Text] [Related]
15. Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys. Becker GL; Gerak LR; Koek W; France CP Psychopharmacology (Berl); 2008 Dec; 201(3):373-82. PubMed ID: 18726088 [TBL] [Abstract][Full Text] [Related]
17. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Shen KF; Crain SM Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746 [TBL] [Abstract][Full Text] [Related]
18. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. Funada M; Schutz CG; Shippenberg TS Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160 [TBL] [Abstract][Full Text] [Related]
19. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat. White DA; Hwang ML; Holtzman SG Pharmacol Biochem Behav; 2005 Jul; 81(3):451-8. PubMed ID: 15907990 [TBL] [Abstract][Full Text] [Related]
20. Duloxetine attenuated morphine withdrawal syndrome in the rat. Charkhpour M; Jafari RM; Ghavimi H; Ghanbarzadeh S; Parvizpur A Drug Res (Stuttg); 2014 Aug; 64(8):393-8. PubMed ID: 24265113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]